PCSK9 inhibitor therapy and 1-year risk of incident heart failure among adults with dyslipidaemia and coronary artery disease: a propensity-matched cohort study
24 April 2026 (08:30 - 18:00)
Organised by: 
Abstract
Slides
About the speaker
Chi-Mei Medical Center, Tainan (Taiwan)
84 More presentations in this session
Doctor E. Nakou (London, GB)
Professor S. Bondarev (Padua, IT)
Mrs N. Hart-Foia (Cluj Napoca, RO)
Doctor M. Audie (Bordeaux, FR)
Access the full session
The Event
ESC Preventive Cardiology 2026
24 April 2026
08:30 CET
You may be interested in
Congress Presentation
Congress Presentation
Congress Presentation
Congress Session
28 August 2022
